Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miltefosine and GM-CSF in Cutaneous Leishmaniasis
NCT03023111Phase 3Completed
- Sponsor
- Hospital Universitário Professor Edgard Santos
- Start
- Jun 2017
- Primary completion
- Aug 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of granulocyte macrophage-colony stimulating factor in cutaneous leishmaniasis (CL), sponsored by Hospital Universitário Professor Edgard Santos. Started Jun 2017; status: completed.
02
Drugs
granulocyte macrophage-colony stimulating factor
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT03023111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03023111.